Parenteral for the treatment of magnesium deficiency
Magnesium deficiency when it causes muscle disorders and oral therapy is not possible.
For the therapy of preeclampsia and eclampsia.
The dosage depends on the severity of the magnesium deficiency or the required need. The ampoule should be injected intravenous (i.v.). The intramuscular injection has to be applied deep. The intravenous injection has to be applied very slowly while the patient is lying (the first 3ml within three minutes). The injection of one ampoule should be repeated with a gap of one or two days.
One ampoule (10 ml) contains 4.095 g magnesiumsulfate-heptahydrate (equals 2000 mg magnesiumsulfate, equals 16.6 mMol magnesium or 33.2 mVal magnesium or 403.8 mg magnesium). For other ingredients, please refer to the direction for use.
Cormagnesin® 400 Injektionslösung. Acxtive substance: magnesiumsulfate-heptahydrate. Therapeutic indications: magnesium deficiency when it causes muscle disorders and oral therapy is not possible. The therapy of preeclampsia and eclampsia. If you have any questions about risks and side effects, please read the patient information leaflet and ask your doctor or pharmacist. Wörwag Pharma GmbH & Co. KG, 71034 Böblingen
10 ampoules à 10 ml solution for infusion: PZN 04652403